| 121/1507 | US=25 / Mama Smith IE. Preoperative endocrine therapy for operable breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 724-9. ISBN 978-0-7817-9117-5. |
| 122/1507 | US=25 / Mama Mamounas EP, Bellon JR. Local-regional therapy considerations in patients receiving preoperative chemotherapy. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 730-44. ISBN 978-0-7817-9117-5. CANCER DE MAMA PRIMARIO; CANCER DE MAMA. TERAPIA EM PACIENTES QUE RECEBERAM QUIMIOTERAPIA PRE-OPERATORIA; BIOPSIA DO LINFONODO SENTINELA; TUMOR DE MAMA IPSILATERAL. RECORRENCIA; QUIMIOTERAPIA PRE-OPERATORIA |
| 123/1507 | US=22 / Pediatria Merchant TE. Radiation therapy in the management of retinoblastoma. In: Rodriguez-Galindo C, Wilson MW. Retinoblastoma. New York: Springer - Verlag, 2010. p. 55-65. (Pediatric Oncology) ISBN 978-0-387-89071-5. RETINOBLASTOMA. TRATAMENTO; RADIOTERAPIA; RETINOBLASTOMA EXTRA-OCULAR DE ALTO RISCO |
| 124/1507 | US=25 / Mama Osborne CK, Harris JR. Management summary on preoperative systemic therapy. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 774. ISBN 978-0-7817-9117-5. |
| 125/1507 | US=25 / Mama Carlson RW. Surveillance of patients following primary therapy. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 823-31. ISBN 978-0-7817-9117-5. TERAPIA PRIMARIA. VIGILANCIA DOS PACIENTES; MAMA CONTRALATERAL; RECIDIVA LOCO-REGIONAL; CANCROS DA MAMA; CANCER DA MAMA. TRATAMENTO |
| 126/1507 | US=25 / Mama Howell SJ, Howell A. Treatment of metastatic breast cancer: endocrine therapy. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 856-76. ISBN 978-0-7817-9117-5. |
| 127/1507 | US=25 / Mama Balsega J. Newer targeted therapy in breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 971-8. ISBN 978-0-7817-9117-5. |
| 128/1507 | US=12 / Urologia Rukstalis DB, Kenneson MA. Prostate cryoablation: successful therapy for clinically localized prostate cancer. In: Su LM. Prostate cancer. Philadelphia: Elsevier Saunders, 2010. p. 193-206. (Early Diagnosis and Treatment of Cancer Series) ISBN 978-1-4160-4575-5. |
| 129/1507 | US=25 / Mama Theriault RL. Bone-directed therapy and breast cancer: bisphosphonates, monoclonal antibody, and radionuclides. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 1038-48. ISBN 978-0-7817-9117-5. TERAPIA DIRIGIDA AOS OSSOS; CANCER DE MAMA; TRATAMENTO DO CANCER PERDA OSSEA; INTERVENCOES PARA PERDA OSSEA; BISFOSFONATOS; ANTICORPO MONOCLONAL DE DOENCA OSSEA. TRATAMENTO |
| 130/1507 | US=9 / Urologia Sharifi N. Androgen deprivation therapy. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 101-7. ISBN 978-1-60327-831-7. TERAPIA DE PRIVACAO DE ANDROGENO; TERAPIA DE PRIVACAO DE ANDROGENO; ANDROGENOS; CANCER DE PROSTATA; TESTOSTERONA |
| 131/1507 | US=9 / Urologia Chau CH, Figg WD. Principles of antiangiogenic therapy. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 197-205. ISBN 978-1-60327-831-7. TERAPIA ANTIANGIOGENICA; ANGIOGENESE; INTERRUPTOR ANGIOGENICO; INIBIDOR DA ANGIOGENESE; DENSIDADE MICROVASCULAR; ANTIANGIOGENICA TERAPIA |
| 132/1507 | US=23-E / Câncer Alcázar JL. Distinguishing benign from malignant complex adnexal masses in ovarian cancer: two-dimensional power-doppler imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 23-33. ISBN 978-90-481-2917-1. DISTINGUIR BENIGNAS DAS MALIGNAS; MASSAS ANEXIAIS EM CANCER DE OVARIO |
| 133/1507 | US=23-E / Câncer Boylan KLM, Skubitz KM, Skubitz APN. Subgroups of ovarian carcinoma: identification using differential gene expression. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 35-58. ISBN 978-90-481-2917-1. |
| 134/1507 | US=23-E / Câncer Sur M, Daya D. Sertolifrom: endometrioid carcinoma of the ovary: diagnosis and prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 59-68. ISBN 978-90-481-2917-1. SERTOLIFROM; CARCINOMA DO OVARIO; ENDOMETRIOID; CARCINOMA DO OVARIO. DIAGNOSTICO; CARCINOMA DO OVARIO. TRATAMENTO |
| 135/1507 | US=23-F / Câncer MacKeigan JP, Gaither LA. Role of RNA interference in understanding the molecular basis of cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 5-20. ISBN 978-90-481-3185-3. CANCER DE CABECA E PESCOCO; CANCER DE TIREOIDE; CANCER. TRATAMENTO; CANCER . DIAGNOSTICO; CANCER. TERAPIA |
| 136/1507 | US=23-E / Câncer Gubbels JAA, Connor JP, Patankar MS. Role of MUC16 (CA125) in the pathogenesis of epithelial ovarian cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 71-84. ISBN 978-90-481-2917-1. MUC16; CA125 NA PATOGENESE DO CANCER EPITELIAL DE OVARIO; CANCER EPITELIAL DE OVARIO; CAMADAS DE DEFESA DO TUMOR DAS CELULAS |
| 137/1507 | US=23-F / Câncer Cho WCS. Cancer biomarkers (an overview). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 21-40. ISBN 978-90-481-3185-3. |
| 138/1507 | US=23-E / Câncer Takano M, Sasaki N, Sugiyama T. Clear cell carcinoma of the ovary: prognosis using cytoreductive surgery. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 85-91. ISBN 978-90-481-2917-1. |
| 139/1507 | US=23-F / Câncer Tokunaga O, Minhajat R, Mori D. Tumor angiogenesis in cancers: expression of CD105 marker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 41-50. ISBN 978-90-481-3185-3. ANGIOGENESE TUMORAL NO CANCER; MARCADORES ANGIOGENICOS CD105 |
| 140/1507 | US=23-F / Câncer Vajtai I, Sahli R. Spindle cell oncocytoma of the adenohysis: integrated clinicopathologic diagnosis by imaging, histology, and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 51-7. ISBN 978-90-481-3185-3. |